Literature DB >> 3362178

Hypertrophic cardiomyopathy and sudden death.

P Nicod1, R Polikar, K L Peterson.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3362178     DOI: 10.1056/NEJM198805123181907

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.

Authors:  William J McKenna; Elijah R Behr
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

2.  Hypertrophic cardiomyopathy in the elderly.

Authors:  L M Shapiro
Journal:  Br Heart J       Date:  1990-05

Review 3.  Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.

Authors:  A Selcuk Adabag; Barry J Maron
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-04       Impact factor: 1.468

4.  Hypertrophic Cardiomyopathy.

Authors:  Elijah R. Behr; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

Review 5.  A potential role for integrin signaling in mechanoelectrical feedback.

Authors:  Borna E Dabiri; Hyungsuk Lee; Kevin Kit Parker
Journal:  Prog Biophys Mol Biol       Date:  2012-07-20       Impact factor: 3.667

6.  Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm.

Authors:  F Alfonso; M P Frenneaux; W J McKenna
Journal:  Br Heart J       Date:  1989-02

7.  Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; F Cecchi; W J McKenna
Journal:  Br Heart J       Date:  1994-12

Review 8.  When is drug therapy warranted to prevent sudden cardiac death?

Authors:  B N Singh
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 9.  Hypertrophic cardiomyopathy as a cause of sudden death.

Authors:  Hubert Seggewiss; Christoph Blank; Barbara Pfeiffer; Angelos Rigopoulos
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

Review 10.  [Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?].

Authors:  Sascha Rolf; Wilhelm Haverkamp
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.